Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, María Eugenia Ibarrarán Viniegra et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trialsAllan Lipton, Susie Jun, Karim Fizazi et al.|European Journal of Cancer|2012Cited by 588
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast CancerBruce E. Hillner, David G. Pfister, James N. Ingle et al.|Journal of Clinical Oncology|2000Cited by 383
Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Jean‐Jacques Body et al.|Cancer|2012Cited by 155
Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Paul J. Kostenuik, Henry G. Bone et al.|European Journal of Cancer|2015Cited by 150